Cannabinoid receptor 1 inhibition in chronic kidney disease: a new therapeutic toolbox
M Dao, H François - Frontiers in Endocrinology, 2021 - frontiersin.org
Chronic kidney disease (CKD) concerns millions of individuals worldwide, with few
therapeutic strategies available to date. Recent evidence suggests that the …
therapeutic strategies available to date. Recent evidence suggests that the …
Na+/K+-ATPase: More than an Electrogenic Pump
RG Contreras, A Torres-Carrillo… - International Journal of …, 2024 - mdpi.com
The sodium pump, or Na+/K+-ATPase (NKA), is an essential enzyme found in the plasma
membrane of all animal cells. Its primary role is to transport sodium (Na+) and potassium …
membrane of all animal cells. Its primary role is to transport sodium (Na+) and potassium …
Cannabinoid receptor type 1 activation causes a water diuresis by inducing an acute central diabetes insipidus in mice
Cannabis and synthetic cannabinoid consumption are increasing worldwide. Cannabis
contains numerous phytocannabinoids that act on the G protein-coupled cannabinoid …
contains numerous phytocannabinoids that act on the G protein-coupled cannabinoid …
[图书][B] Neurobiology and Physiology of the Endocannabinoid System
VB Patel, VR Preedy, CR Martin - 2023 - books.google.com
Neurobiology and Physiology of the Endocannabinoid System offers readers a
comprehensive reference on the neurobiology of this system and the use of cannabimimetic …
comprehensive reference on the neurobiology of this system and the use of cannabimimetic …
Le blocage du récepteur cannabinoïde de type 1: une nouvelle piste thérapeutique dans la maladie rénale chronique
M Dao - 2021 - theses.hal.science
La modulation du système endocannabinoïde, en particulier le blocage de son récepteur de
type 1 (CB1R), pourrait être un outil thérapeutique dans la prise en charge de la maladie …
type 1 (CB1R), pourrait être un outil thérapeutique dans la prise en charge de la maladie …